| Title : The dipeptidyl peptidase-4 inhibitor linagliptin ameliorates LPS-induced acute lung injury by maintenance of pulmonary microvascular barrier via activating the Epac1\/AKT pathway - Zhang_2022_Biomed.Pharmacother_155_113704 |
| Author(s) : Zhang N , Tang S , Zhang J , Pei B , Pang T , Sun G |
| Ref : Biomed Pharmacother , 155 :113704 , 2022 |
| Abstract : |
| PubMedSearch : Zhang_2022_Biomed.Pharmacother_155_113704 |
| PubMedID: 36115114 |